Cushman & Wakefield Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Cushman & Wakefield de 31.5% y 4.7% por año respectivamente. Se prevé que el BPA crezca en un 31.4% al año. Se espera que la rentabilidad financiera sea de 15.6% en 3 años.
Información clave
31.6%
Tasa de crecimiento de los beneficios
31.2%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Real Estate | 30.7% |
| Tasa de crecimiento de los ingresos | 5.2% |
| Rentabilidad financiera futura | 14.1% |
| Cobertura de analistas | Good |
| Última actualización | 03 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
There May Be Reason For Hope In Cushman & Wakefield's (NYSE:CWK) Disappointing Earnings
May 07
Cushman & Wakefield plc's (NYSE:CWK) Revenues Are Not Doing Enough For Some Investors
Apr 09Cushman & Wakefield: A Hold Despite Earnings Beat
Feb 23Is There An Opportunity With Cushman & Wakefield plc's (NYSE:CWK) 27% Undervaluation?
Feb 22Cushman & Wakefield (NYSE:CWK) Use Of Debt Could Be Considered Risky
Feb 01Cushman & Wakefield plc's (NYSE:CWK) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Dec 20Is It Too Late To Consider Buying Cushman & Wakefield plc (NYSE:CWK)?
Dec 14Cushman & Wakefield: Still Neutral Considering Various Factors
Nov 23Cushman & Wakefield plc's (NYSE:CWK) Intrinsic Value Is Potentially 32% Above Its Share Price
Nov 22Cushman & Wakefield (NYSE:CWK) Has No Shortage Of Debt
Nov 01Cushman & Wakefield: Watch Capital Allocation And Financial Outlook
Sep 14Is It Time To Consider Buying Cushman & Wakefield plc (NYSE:CWK)?
Sep 11Is There An Opportunity With Cushman & Wakefield plc's (NYSE:CWK) 31% Undervaluation?
Aug 13Cushman & Wakefield: No Catalysts In Sight
Jul 04Does Cushman & Wakefield (NYSE:CWK) Have A Healthy Balance Sheet?
Jul 04Should You Investigate Cushman & Wakefield plc (NYSE:CWK) At US$9.05?
Jun 13Are Investors Undervaluing Cushman & Wakefield plc (NYSE:CWK) By 35%?
May 05Cushman & Wakefield (NYSE:CWK) Has A Somewhat Strained Balance Sheet
Mar 30At US$13.38, Is It Time To Put Cushman & Wakefield plc (NYSE:CWK) On Your Watch List?
Feb 24Cushman & Wakefield Non-GAAP EPS of $0.46 misses by $0.04, revenue of $2.6B beats by $160M
Feb 23Cushman & Wakefield: Challenging Outlook
Jan 29Cushman & Wakefield plc (NYSE:CWK) Could Be Riskier Than It Looks
Jan 24An Intrinsic Calculation For Cushman & Wakefield plc (NYSE:CWK) Suggests It's 35% Undervalued
Jan 09Does Cushman & Wakefield (NYSE:CWK) Have A Healthy Balance Sheet?
Dec 23Cushman & Wakefield: All Eyes On Third-Quarter Results And M&A
Oct 27Is Now An Opportune Moment To Examine Cushman & Wakefield plc (NYSE:CWK)?
Oct 01Cushman & Wakefield: A Mixed Outlook Despite Q2 Earnings Beat
Aug 11Here's Why Cushman & Wakefield (NYSE:CWK) Has A Meaningful Debt Burden
Aug 08Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 10,678 | 294 | 245 | 314 | 5 |
| 12/31/2025 | 10,147 | 231 | 211 | 277 | 5 |
| 12/31/2024 | 9,863 | 154 | 192 | 251 | 1 |
| 3/31/2024 | 9,429 | 12 | 197 | 249 | N/A |
| 12/31/2023 | 9,494 | -35 | 101 | 152 | N/A |
| 9/30/2023 | 9,588 | -75 | 152 | 194 | N/A |
| 6/30/2023 | 9,817 | -18 | 16 | 57 | N/A |
| 3/31/2023 | 10,024 | 75 | -56 | -14 | N/A |
| 12/31/2022 | 10,106 | 196 | -2 | 49 | N/A |
| 9/30/2022 | 10,342 | 312 | 38 | 105 | N/A |
| 6/30/2022 | 10,160 | 357 | 153 | 216 | N/A |
| 3/31/2022 | 9,796 | 313 | 348 | 408 | N/A |
| 12/31/2021 | 9,389 | 250 | 496 | 550 | N/A |
| 9/30/2021 | 8,778 | 77 | 389 | 435 | N/A |
| 6/30/2021 | 8,377 | -29 | 305 | 349 | N/A |
| 3/31/2021 | 7,872 | -183 | 151 | 195 | N/A |
| 12/31/2020 | 7,844 | -220 | -79 | -38 | N/A |
| 9/30/2020 | 8,178 | -190 | 88 | 147 | N/A |
| 6/30/2020 | 8,365 | -141 | 60 | 128 | N/A |
| 3/31/2020 | 8,743 | -34 | 158 | 234 | N/A |
| 12/31/2019 | 8,751 | 0 | 189 | 269 | N/A |
| 9/30/2019 | 8,545 | -21 | -133 | -63 | N/A |
| 6/30/2019 | 8,503 | -74 | -64 | 19 | N/A |
| 3/31/2019 | 8,355 | -114 | -124 | -46 | N/A |
| 12/31/2018 | 8,220 | -186 | -86 | -2 | N/A |
| 9/30/2018 | 7,871 | -143 | 112 | 207 | N/A |
| 6/30/2018 | 7,504 | -181 | -28 | 64 | N/A |
| 3/31/2018 | 7,230 | -194 | -113 | 8 | N/A |
| 12/31/2017 | 6,924 | -221 | N/A | 4 | N/A |
| 12/31/2016 | 6,216 | -434 | N/A | -335 | N/A |
| 12/31/2015 | 4,193 | -474 | N/A | -44 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (28.3% al año) de CWK es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (28.3% al año) de CWK crezcan más rápidamente que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de CWK crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (4.6% al año) de CWK crezcan más despacio que el mercado de US (7.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 4.6% al año) de CWK crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de CWK sea baja dentro de 3 años (15.6%).